← Leaderboards
Xueling Wu
Columbia University Health Sciences
$10,163,675
Attributed
$12,412,969
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2014–25$2.5M$1.9M$1.3M$625K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,412,969 · 7
By mechanism
R01$7,910,602 · 3
R61$2,999,059 · 1
R56$623,828 · 1
R21$522,850 · 1
R03$356,630 · 1
Top collaborators
- Zizhang Sheng3 shared
- Masahiro Yamashita3 shared
- Michael T Yin3 shared
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- John R. Edwards$5,139,811
- Zizhang Sheng$1,896,462
- Christopher Edward Mason$16,419,065
- Kenneth L Shepard$17,951,329
- Emily Margaret Mace$6,560,188
Others in their field
Top investigators on “Antibodies”
- Lawrence Corey · Fred Hutchinson Cancer Center$525,765,536
- Bambra Strokes · Ppd Development Lp$461,655,950
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$385,009,925
- Barton F Haynes · Duke University$372,611,596
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$323,573,074
- Dennis R. Burton · Scripps Research Institute$306,733,901
Research focus
AntibodiesSamplingVirusNeutralizing AntibodyMonoclonal AntibodiesPlasmaHiv-1EpitopesInfectionB-LymphocytesAntibody RepertoireViralPublic Health RelevanceImmune SystemResponsePropertyCellsAntigensMacaca MulattaCohort StudiesSimian Human Immunodeficiency VirusPeripheral Blood Mononuclear CellHiv InfectionsMemory B-Lymphocyte
Grant awards (22)
Quick and Accurate Measurements of HIV Broadly Neutralizing Antibody Susceptibility$994,203
R61 · FY2025 · AI
Characterization of HIV-1 IgA bNAbs and ADCP function$807,667
R01 · FY2025 · AI · contact PI
Immune profiling of antibodies and B cells that recognize HIV and substances in people who use substances and live with HIV (PWUSH)$356,630
R03 · FY2025 · DA · contact PI
Characterization of HIV-1 IgA bNAbs and ADCP function$27,154
R01 · FY2025 · AI · contact PI
Characterization of HIV-1 IgA bNAbs and ADCP function$1,042,788
R01 · FY2024 · AI · contact PI
Quick and Accurate Measurements of HIV Broadly Neutralizing Antibody Susceptibility$1,002,428
R61 · FY2024 · AI
Quick and Accurate Measurements of HIV Broadly Neutralizing Antibody Susceptibility$1,002,428
R61 · FY2023 · AI · contact PI
Characterization of HIV-1 IgA bNAbs and ADCP function$548,449
R01 · FY2023 · AI · contact PI
Characterization of HIV-1 IgA bNAbs and ADCP function$623,828
R56 · FY2022 · AI · contact PI
Characterization of HIV-1 IgA bNAbs and ADCP function$264,763
R01 · FY2022 · AI · contact PI
Novel HIV-1 Env trimer probes for efficient isolation of broadly neutralizing antibodies$497,160
R01 · FY2019 · AI · contact PI
Novel HIV-1 Env trimer probes for efficient isolation of broadly neutralizing antibodies$133,024
R01 · FY2019 · AI · contact PI
Novel HIV-1 Env trimer probes for efficient isolation of broadly neutralizing antibodies$631,830
R01 · FY2018 · AI · contact PI
Deep Sequencing to Identify B-Cell Precursors of HIV-1 Neutralizing Antibodies$487,000
R01 · FY2018 · AI · contact PI
Novel HIV-1 Env trimer probes for efficient isolation of broadly neutralizing antibodies$633,429
R01 · FY2017 · AI · contact PI
Deep Sequencing to Identify B-Cell Precursors of HIV-1 Neutralizing Antibodies$487,000
R01 · FY2017 · AI · contact PI
Novel HIV-1 Env trimer probes for efficient isolation of broadly neutralizing antibodies$729,983
R01 · FY2016 · AI · contact PI
Deep Sequencing to Identify B-Cell Precursors of HIV-1 Neutralizing Antibodies$659,105
R01 · FY2016 · AI · contact PI
Deep Sequencing to Identify B-Cell Precursors of HIV-1 Neutralizing Antibodies$487,000
R01 · FY2015 · AI · contact PI
Characterization and Generalization of a Novel Immunogenic Target on HIV-1 gp120$237,000
R21 · FY2015 · AI · contact PI
Deep Sequencing to Identify B-Cell Precursors of HIV-1 Neutralizing Antibodies$474,250
R01 · FY2014 · AI · contact PI
Characterization and Generalization of a Novel Immunogenic Target on HIV-1 gp120$285,850
R21 · FY2014 · AI · contact PI